TickerFactsScreenerDevelopers

Vanda Pharmaceuticals Inc. (VNDA) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $46.02M2009: $23.03M2010: $37.73M2011: $33.47M2012: $9.90M2013: $44.12M2014: $160.82M2015: $133.03M2016: $131.33M2017: $131.39M2018: $275.42M2019: $410.94M2020: $453.27M2021: $504.93M2022: $527.20M2023: $544.91M2024: $538.55M2025: $327.19M$327.19M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$327.19M-39.2%
2024$538.55M-1.2%
2023$544.91M+3.4%
2022$527.20M+4.4%
2021$504.93M+11.4%
2020$453.27M+10.3%
2019$410.94M+49.2%
2018$275.42M+109.6%
2017$131.39M+0.0%
2016$131.33M-1.3%
2015$133.03M-17.3%
2014$160.82M+264.5%
2013$44.12M+345.5%
2012$9.90M-70.4%
2011$33.47M-11.3%
2010$37.73M+63.8%
2009$23.03M-50.0%
2008$46.02M—